Treatment characteristic | Total | Age at treatment | CIRS | ||||
---|---|---|---|---|---|---|---|
75 +  | Under 75 | P-value | 8 +  | Under 8 | P-value | ||
Achieved full dose of chlorambucil | 26 (38.81) | 6 (20.69) | 20 (52.63) |  < 0.01a | 15 (40.54) | 11 (36.67) | 0.75a |
Completed 6 cycles of obinutuzumab | 46 (68.66) | 18 (62.07) | 28 (73.68) | 0.31a | 25 (67.57) | 21 (70.00) | 0.83a |
Number of chlorambucil doses, median (range) | 10 (1–12) | 8 (1–12) | 10.5 (1–12) | 0.06b | 10 (1–12) | 9 (1–12) | 0.78b |
Number of obinutuzumab doses, median (range) | 9 (1–9) | 8 (1–9) | 9 (4–9) | - | 9 (2–9) | 9 (1–9) | - |